Envista Holdings (NVST) Shares Outstanding (Weighted Average) (2017 - 2026)

Envista Holdings (NVST) recorded quarterly Shares Outstanding (Weighted Average) of $163.9 million in Q2 2026, down 2.44% quarter-over-quarter from $168.0 million in Q4 2025, and down 4.93% on a YoY basis from $172.4 million in Q2 2025.

Envista Holdings (NVST) Shares Outstanding (Weighted Average) (2017 - 2026) Analysis & Trends

Envista Holdings' Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $163.9 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Weighted Average) fell 4.93% year-over-year to $163.9 million; the TTM figure through Apr 2026 stood at $163.9 million (down 4.93% YoY), while the FY2025 annual figure was $168.0 million, down 2.44% from the prior year.
  • Shares Outstanding (Weighted Average) was $163.9 million for Q2 2026 at Envista Holdings, down from $168.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $172.4 million in Q1 2025 to a low of $162.2 million in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $167.2 million across 5 years, with a median of $166.9 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Weighted Average) rose 5.07% in 2024, then fell 4.93% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $162.9 million in 2022, then grew by 2.46% to $166.9 million in 2023, then advanced by 3.18% to $172.2 million in 2024, then declined by 2.44% to $168.0 million in 2025, then dropped by 2.44% to $163.9 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $163.9 million (Q2 2026), $168.0 million (Q4 2025), and $169.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Intuitive Surgical 147.79 Bn 143.40 Bn 1.83 Bn 354.90 Mn
2 Becton Dickinson 41.23 Bn 40.22 Bn 2.15 Bn 283.14 Mn
3 Medline 30.57 Bn 36.41 Bn 1.84 Bn 819.00 Mn
4 Resmed 28.04 Bn 26.38 Bn 890.98 Mn 145.34 Mn
5 West Pharmaceutical Services 23.76 Bn 23.24 Bn 296.40 Mn 72.00 Mn
6 Solventum 13.40 Bn 13.40 Bn 1.10 Bn 174.20 Mn
7 Cooper Companies 13.18 Bn 13.04 Bn 735.40 Mn 195.40 Mn
8 Align Technology 12.72 Bn 11.66 Bn 736.59 Mn 71.43 Mn
9 Baxter International 10.71 Bn 8.67 Bn 891.00 Mn 515.00 Mn
10 Envista Holdings 4.04 Bn 2.96 Bn 390.10 Mn 163.90 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 163.90 Mn
Dec 31, 2025 168.00 Mn
Sep 26, 2025 169.20 Mn
Jun 27, 2025 170.70 Mn
Mar 28, 2025 172.40 Mn
Dec 31, 2024 172.20 Mn
Sep 27, 2024 172.10 Mn
Jun 28, 2024 172.00 Mn
Mar 29, 2024 171.90 Mn
Dec 31, 2023 166.90 Mn
Sep 29, 2023 165.30 Mn
Jun 30, 2023 164.00 Mn
Mar 31, 2023 163.60 Mn
Dec 31, 2022 162.90 Mn
Sep 30, 2022 162.70 Mn
Jul 1, 2022 162.60 Mn
Apr 1, 2022 162.20 Mn
Dec 31, 2021 161.20 Mn
Oct 1, 2021 161.50 Mn
Jul 2, 2021 160.80 Mn